Forecasting for the Pharmaceutical Indus
Kort om boken
Bok med hardt omslag.
Heftet bok med mykt omslag.
Bok med tykke, stive sider.
Digitalt format. E-bok kan leses i ARK-appen eller på Kindle. Bøkene kan også lastes ned fra Din side.
Digitalt format. Nedlastbar lydbok kan lyttes til i ARK-appen. Bøkene kan også lastes ned fra Din side.
Lydbok på digikort. Krever Digispiller.
Lydbok eller musikk på CD. Krever CD-spiller eller annen kompatibel avspiller.
Vinylplate. Krever platespiller.
DVD-film. Krever DVD-spiller eller annen kompatibel avspiller.
Blu-ray-film. Krever Blu-ray-spiller eller annen kompatibel avspiller.
Om Forecasting for the Pharmaceutical Indus
Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making.In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex black box equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion.Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in- market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge.The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars.